RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention-Reference-Cited by-同舟云学术

RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention

Published:2013-10 Issue:2 Volume:80 Page:415-428
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

Donnelly Christopher J.,Zhang Ping-Wu,Pham Jacqueline T.,Haeusler Aaron R.,Mistry Nipun A.,Vidensky Svetlana,Daley Elizabeth L.,Poth Erin M.,Hoover Benjamin,Fines Daniel M.,Maragakis Nicholas,Tienari Pentti J.,Petrucelli Leonard,Traynor Bryan J.,Wang Jiou,Rigo Frank,Bennett C. Frank,Blackshaw Seth,Sattler Rita,Rothstein Jeffrey D.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference49 articles.

1. Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons;Almeida;Acta Neuropathol.,2013

2. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS;Ash;Neuron,2013

3. Microsatellite repeat instability and neurological disease;Brouwer;Bioessays,2009

4. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains;Chen;RNA,2000

5. Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis;Ciura;Ann. Neurol.,2013

Cited by 786 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAR3 modulates neuronal differentiation and regulates mRNA stability and translation;Nucleic Acids Research;2024-09-01

2. Identification of selective and non-selective C9ORF72 targeting in vivo active siRNAs;Molecular Therapy - Nucleic Acids;2024-09

3. A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV-C9ORF72 (G₄C₂)₆₆mouse model;2024-08-27

4. Poly-GR repeats associated with ALS/FTD gene C9ORF72 impair translation elongation and induce a ribotoxic stress response in neurons;Science Signaling;2024-08-06

5. The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis;Heliyon;2024-08